pharma news today glp-1 2025 🚨Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products⁣ ⁣ 📱🧪GLP-1 receptor agonists currently have a strong social media presence, often accompanied by unrealistic promises of weight loss. Criminal counterfeiters glp-1 drugs pharmaceutical companies news

Targeting the DNA repair endonuclease ERCC1-XPF with green tea polyphenol epigallocatechin-3-gallate (EGCG) and its prodrug to enhance cisplatin efficacy in human cancer cells

The abdominal region often retains stubborn fat deposits in the lower belly, flanks, and around the waistline that resist further reduction

A new Australian meta-analysis of more than 85,000 patients, including those with and without diabetes, found GLP-1 receptor agonists reduced the risk of kidney failure by 16%, and the worsening of kidney function by 22%

J Immunol 183 : 46014608 Fitzpatrick AM, Holguin F, Teague WG, Brown LA 2008 Alveolar macrophage phagocytosis is impaired in children with poorly controlled asthma

Every peptide is crafted with the same attention to purity and consistency that makes proper post-reconstitution storage worth protecting

Step two Injectable GHK-CU Delivered directly into the body, bypassing the skin barrier for deeper tissue reach